REFERENCES
1. Smeriglio A, Barreca D, Bellocco E, Trombetta D. Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects. Br J Pharmacol 2017;174:1244-62.
2. Mannino G, Chinigò G, Serio G, et al. Proanthocyanidins and where to find them: a meta-analytic approach to investigate their chemistry, biosynthesis, distribution, and effect on human health. Antioxidants 2021;10:1229.
3. Rauf A, Imran M, Abu-Izneid T, et al. Proanthocyanidins: a comprehensive review. Biomed Pharmacother 2019;116:108999.
4. Favari C, Mena P, Curti C, Del Rio D, Angelino D. Flavan-3-ols: catechins and proanthocyanidins. In: Tomás-barberán FA, González-sarrías A, García-villalba R, editors. Dietary polyphenols. Wiley; 2020. pp. 283-317.
5. Feldman F, Koudoufio M, El-Jalbout R, et al. Cranberry proanthocyanidins as a therapeutic strategy to curb metabolic syndrome and fatty liver-associated disorders. Antioxidants 2022;12:90.
6. de la Iglesia R, Milagro FI, Campión J, Boqué N, Martínez JA. Healthy properties of proanthocyanidins. Biofactors 2010;36:159-68.
7. Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 2018;57:1-24.
8. Tao W, Zhang Y, Shen X, et al. Rethinking the mechanism of the health benefits of proanthocyanidins: absorption, metabolism, and interaction with gut microbiota. Compr Rev Food Sci Food Saf 2019;18:971-85.
9. Lessard-Lord J, Roussel C, Guay V, Desjardins Y. Assessing the gut microbiota’s ability to metabolize oligomeric and polymeric flavan-3-ols from aronia and cranberry. Mol Nutr Food Res 2024;68:e2300641.
10. Coleman CM, Ferreira D. Oligosaccharides and complex carbohydrates: a new paradigm for cranberry bioactivity. Molecules 2020;25:881.
11. Karboune S, Davis EJ, Fliss I, Spadoni Andreani E. In-vitro digestion and fermentation of cranberry extracts rich in cell wall oligo/polysaccharides. J Funct Foods 2022;92:105039.
12. Sallam IE, Abdelwareth A, Attia H, et al. Effect of gut microbiota biotransformation on dietary tannins and human health implications. Microorganisms 2021;9:965.
13. Ma G, Chen Y. Polyphenol supplementation benefits human health via gut microbiota: a systematic review via meta-analysis. J Funct Foods 2020;66:103829.
14. Rodríguez-Daza MC, Pulido-Mateos EC, Lupien-Meilleur J, Guyonnet D, Desjardins Y, Roy D. Polyphenol-mediated gut microbiota modulation: toward prebiotics and further. Front Nutr 2021;8:689456.
15. van Dorsten FA, Peters S, Gross G, et al. Gut microbial metabolism of polyphenols from black tea and red wine/grape juice is source-specific and colon-region dependent. J Agric Food Chem 2012;60:11331-42.
16. Wu T, Grootaert C, Pitart J, et al. Aronia (aronia melanocarpa) polyphenols modulate the microbial community in a simulator of the human intestinal microbial ecosystem (SHIME) and decrease secretion of proinflammatory markers in a caco-2/endothelial cell coculture model. Mol Nutr Food Res 2018;62:e1800607.
17. Rodríguez-Daza MC, Daoust L, Boutkrabt L, et al. Wild blueberry proanthocyanidins shape distinct gut microbiota profile and influence glucose homeostasis and intestinal phenotypes in high-fat high-sucrose fed mice. Sci Rep 2020;10:2217.
18. Cires MJ, Navarrete P, Pastene E, et al. Effect of a proanthocyanidin-rich polyphenol extract from avocado on the production of amino acid-derived bacterial metabolites and the microbiota composition in rats fed a high-protein diet. Food Funct 2019;10:4022-35.
19. Chen Y, Wang J, Zou L, Cao H, Ni X, Xiao J. Dietary proanthocyanidins on gastrointestinal health and the interactions with gut microbiota. Crit Rev Food Sci Nutr 2023;63:6285-308.
20. Dueñas M, Muñoz-González I, Cueva C, et al. A survey of modulation of gut microbiota by dietary polyphenols. Biomed Res Int 2015;2015:850902.
21. Taibi A, Lofft Z, Laytouni-Imbriaco B, Comelli EM. The role of intestinal microbiota and microRNAs in the anti-inflammatory effects of cranberry: from pre-clinical to clinical studies. Front Nutr 2023;10:1092342.
22. Redondo-Castillejo R, Garcimartín A, Hernández-Martín M, et al. Proanthocyanidins: impact on gut microbiota and intestinal action mechanisms in the prevention and treatment of metabolic syndrome. Int J Mol Sci 2023;24:5369.
23. Anhê FF, Pilon G, Roy D, Desjardins Y, Levy E, Marette A. Triggering Akkermansia with dietary polyphenols: a new weapon to combat the metabolic syndrome? Gut Microbes 2016;7:146-53.
24. Rodríguez-Daza MC, de Vos WM. Polyphenols as drivers of a homeostatic gut microecology and immuno-metabolic traits of Akkermansia muciniphila: from mouse to man. Int J Mol Sci 2022;24:45.
25. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013;110:9066-71.
26. Andersen-Civil AIS, Arora P, Williams AR. Regulation of enteric infection and immunity by dietary proanthocyanidins. Front Immunol 2021;12:637603.
27. Dupont D, Alric M, Blanquet-Diot S, et al. Can dynamic in vitro digestion systems mimic the physiological reality? Crit Rev Food Sci Nutr 2019;59:1546-62.
28. Lessard-Lord J, Roussel C, Lupien-Meilleur J, et al. Short term supplementation with cranberry extract modulates gut microbiota in human and displays a bifidogenic effect. NPJ Biofilms Microbiomes 2024;10:18.
29. Roussel C, Chabaud S, Lessard-Lord J, et al. UPEC colonic-virulence and urovirulence are blunted by proanthocyanidins-rich cranberry extract microbial metabolites in a gut model and a 3D tissue-engineered urothelium. Microbiol Spectr 2022;10:e0243221.
30. Dufour C, Villa-Rodriguez JA, Furger C, et al. Cellular antioxidant effect of an aronia extract and its polyphenolic fractions enriched in proanthocyanidins, phenolic acids, and anthocyanins. Antioxidants 2022;11:1561.
31. Jakobek L, García-villalba R, Tomás-barberán FA. Polyphenolic characterisation of old local apple varieties from Southeastern European region. J Food Compos Anal 2013;31:199-211.
32. Roussel C, De Paepe K, Galia W, et al. Spatial and temporal modulation of enterotoxigenic E. coli H10407 pathogenesis and interplay with microbiota in human gut models. BMC Biol 2020;18:141.
33. Van de Wiele T, Van den Abbeele P, Ossieur W, Possemiers S, Marzorati M. The simulator of the human intestinal microbial ecosystem (SHIME®). In: Verhoeckx K, Cotter P, López-expósito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. The Impact of food bioactives on health. Cham: Springer International Publishing; 2015. pp. 305-17.
34. Geirnaert A, Wang J, Tinck M, et al. Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model. FEMS Microbiol Ecol 2015;91:fiv054.
35. Roussel C, Anunciação Braga Guebara S, Plante PL, Desjardins Y, Di Marzo V, Silvestri C. Short-term supplementation with ω-3 polyunsaturated fatty acids modulates primarily mucolytic species from the gut luminal mucin niche in a human fermentation system. Gut Microbes 2022;14:2120344.
36. De Paepe K, Verspreet J, Verbeke K, Raes J, Courtin CM, Van de Wiele T. Introducing insoluble wheat bran as a gut microbiota niche in an in vitro dynamic gut model stimulates propionate and butyrate production and induces colon region specific shifts in the luminal and mucosal microbial community. Environ Microbiol 2018;20:3406-26.
37. Kurtz ZD, Müller CL, Miraldi ER, Littman DR, Blaser MJ, Bonneau RA. Sparse and compositionally robust inference of microbial ecological networks. PLoS Comput Biol 2015;11:e1004226.
38. Banerjee S, Schlaeppi K, van der Heijden MGA. Keystone taxa as drivers of microbiome structure and functioning. Nat Rev Microbiol 2018;16:567-76.
39. Takagaki A, Nanjo F. Bioconversion of (-)-epicatechin, (+)-epicatechin, (-)-catechin, and (+)-catechin by (-)-epigallocatechin-metabolizing bacteria. Biol Pharm Bull 2015;38:789-94.
40. Takagaki A, Kato Y, Nanjo F. Isolation and characterization of rat intestinal bacteria involved in biotransformation of
42. Kutschera M, Engst W, Blaut M, Braune A. Isolation of catechin-converting human intestinal bacteria. J Appl Microbiol 2011;111:165-75.
43. Stoupi S, Williamson G, Drynan JW, Barron D, Clifford MN. Procyanidin B2 catabolism by human fecal microflora: partial characterization of ‘dimeric’ intermediates. Arch Biochem Biophys 2010;501:73-8.
44. Sánchez-Patán F, Tabasco R, Monagas M, et al. Capability of Lactobacillus plantarum IFPL935 to catabolize flavan-3-ol compounds and complex phenolic extracts. J Agric Food Chem 2012;60:7142-51.
45. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021;19:55-71.
46. de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut 2022;71:1020-32.
47. Firrman J, Liu L, Tanes C, et al. Metabolic analysis of regionally distinct gut microbial communities using an in vitro platform. J Agric Food Chem 2020;68:13056-67.
48. Lessard-Lord J, Lupien-Meilleur J, Roussel C, et al. Mathematical modeling of fluid dynamics in in vitro gut fermentation systems: a new tool to improve the interpretation of microbial metabolism. FASEB J 2024;38:e23398.
49. Cheng H, Zhang D, Wu J, et al. Interactions between gut microbiota and polyphenols: a mechanistic and metabolomic review. Phytomedicine 2023;119:154979.
50. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017;19:29-41.
51. Hotchkiss AT Jr, Renye JA Jr, White AK, et al. Cranberry arabino-xyloglucan and pectic oligosaccharides induce lactobacillus growth and short-chain fatty acid production. Microorganisms 2022;10:1346.
52. Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 2016;7:979.
53. Belenguer A, Duncan SH, Calder AG, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 2006;72:3593-9.
54. Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett 2015;362:fnv176.
55. Moens F, Weckx S, De Vuyst L. Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii. Int J Food Microbiol 2016;231:76-85.
56. Özcan E, Rozycki MR, Sela DA. Cranberry proanthocyanidins and dietary oligosaccharides synergistically modulate Lactobacillus plantarum physiology. Microorganisms 2021;9:656.
57. Gao C, Xu L, Montoya L, et al. Co-occurrence networks reveal more complexity than community composition in resistance and resilience of microbial communities. Nat Commun 2022;13:3867.
58. Blanchet FG, Cazelles K, Gravel D. Co-occurrence is not evidence of ecological interactions. Ecol Lett 2020;23:1050-63.
59. Berry D, Widder S. Deciphering microbial interactions and detecting keystone species with co-occurrence networks. Front Microbiol 2014;5:219.
60. Weiss AS, Niedermeier LS, von Strempel A, et al. Nutritional and host environments determine community ecology and keystone species in a synthetic gut bacterial community. Nat Commun 2023;14:4780.
61. Tudela H, Claus SP, Saleh M. Next generation microbiome research: identification of keystone species in the metabolic regulation of host-gut microbiota interplay. Front Cell Dev Biol 2021;9:719072.
62. Wortelboer K, Koopen AM, Herrema H, de Vos WM, Nieuwdorp M, Kemper EM. From fecal microbiota transplantation toward next-generation beneficial microbes: the case of Anaerobutyricum soehngenii. Front Med 2022;9:1077275.
63. Tourlousse DM, Sakamoto M, Miura T, et al. Complete genome sequence of Flavonifractor plautii JCM 32125T. Microbiol Resour Announc 2020;9:e00135-20.
64. Mikami A, Ogita T, Namai F, Shigemori S, Sato T, Shimosato T. Oral administration of Flavonifractor plautii, a bacteria increased with green tea consumption, promotes recovery from acute colitis in mice via suppression of IL-17. Front Nutr 2020;7:610946.
65. Ogita T, Yamamoto Y, Mikami A, Shigemori S, Sato T, Shimosato T. Oral administration of Flavonifractor plautii strongly suppresses Th2 immune responses in mice. Front Immunol 2020;11:379.
66. Mikami A, Ogita T, Namai F, Shigemori S, Sato T, Shimosato T. Oral administration of Flavonifractor plautii attenuates inflammatory responses in obese adipose tissue. Mol Biol Rep 2020;47:6717-25.
67. El Hage R, Hernandez-Sanabria E, Calatayud Arroyo M, Props R, Van de Wiele T. Propionate-producing consortium restores antibiotic-induced dysbiosis in a dynamic in vitro model of the human intestinal microbial ecosystem. Front Microbiol 2019;10:1206.
68. Yoshida N, Emoto T, Yamashita T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 2018;138:2486-98.
69. Kumari M, Singh P, Nataraj BH, et al. Fostering next-generation probiotics in human gut by targeted dietary modulation: an emerging perspective. Food Res Int 2021;150:110716.
70. Belzer C, Chia LW, Aalvink S, et al. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. mBio 2017;8:e00770-17.
71. Perraudeau F, McMurdie P, Bullard J, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care 2020;8:e001319.
72. Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Author Correction: Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol 2022;19:682.
73. Daniel N, Gewirtz AT, Chassaing B. Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism. Gut 2023;72:906-17.
74. Bui TPN, Shetty SA, Lagkouvardos I, et al. Comparative genomics and physiology of the butyrate-producing bacterium Intestinimonas butyriciproducens. Environ Microbiol Rep 2016;8:1024-37.
75. Bui TPN, Troise AD, Nijsse B, Roviello GN, Fogliano V, de Vos WM. Intestinimonas-like bacteria are important butyrate producers that utilize Nε-fructosyllysine and lysine in formula-fed infants and adults. J Funct Foods 2020;70:103974.
76. Ahn S, Jin TE, Chang DH, et al. Agathobaculum butyriciproducens gen. nov. sp. nov., a strict anaerobic, butyrate-producing gut bacterium isolated from human faeces and reclassification of Eubacterium desmolans as Agathobaculum desmolans comb. nov. Int J Syst Evol Microbiol 2016;66:3656-61.
77. Song L, Dong X. Hydrogenoanaerobacterium saccharovorans gen. nov., sp. nov., isolated from H2-producing UASB granules. Int J Syst Evol Microbiol 2009;59:295-9.
78. Huang X, Oshima T, Tomita T, Fukui H, Miwa H. Butyrate alleviates cytokine-induced barrier dysfunction by modifying claudin-2 levels. Biology 2021;10:205.
79. Daniel N, Lécuyer E, Chassaing B. Host/microbiota interactions in health and diseases - time for mucosal microbiology! Mucosal Immunol 2021;14:1006-16.
80. Etienne-Mesmin L, Chassaing B, Desvaux M, et al. Experimental models to study intestinal microbes-mucus interactions in health and disease. FEMS Microbiol Rev 2019;43:457-89.
81. Sicard JF, Le Bihan G, Vogeleer P, Jacques M, Harel J. Interactions of intestinal bacteria with components of the intestinal mucus. Front Cell Infect Microbiol 2017;7:387.
82. Sevrin G, Massier S, Chassaing B, et al. Adaptation of adherent-invasive E. coli to gut environment: impact on flagellum expression and bacterial colonization ability. Gut Microbes 2020;11:364-80.
83. Loo YT, Howell K, Chan M, Zhang P, Ng K. Modulation of the human gut microbiota by phenolics and phenolic fiber-rich foods. Compr Rev Food Sci Food Saf 2020;19:1268-98.
84. Gutierrez A, Pucket B, Engevik MA. Bifidobacterium and the intestinal mucus layer. Microbiome Res Rep 2023;2:36.
85. Monteagudo-Mera A, Rastall RA, Gibson GR, Charalampopoulos D, Chatzifragkou A. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl Microbiol Biotechnol 2019;103:6463-72.
86. Zhang D, Verstrepen L, De Medts J, et al. A cranberry concentrate decreases adhesion and invasion of Escherichia coli (AIEC) LF82 in vitro. Pathogens 2021;10:1217.
87. Duranti S, Milani C, Lugli GA, et al. Evaluation of genetic diversity among strains of the human gut commensal Bifidobacterium adolescentis. Sci Rep 2016;6:23971.
88. Mulualem DM, Agbavwe C, Ogilvie LA, et al. Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase. Appl Microbiol Biotechnol 2021;105:1063-78.
89. Yu R, Zuo F, Ma H, Chen S. Exopolysaccharide-producing Bifidobacterium adolescentis strains with similar adhesion property induce differential regulation of inflammatory immune response in Treg/Th17 axis of DSS-colitis mice. Nutrients 2019;11:782.
90. Fan L, Qi Y, Qu S, et al. B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling. Gut Microbes 2021;13:1-17.
91. Lin Y, Fan L, Qi Y, et al. Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis. J Exp Clin Cancer Res 2023;42:172.
92. Wang B, Kong Q, Cui S, et al. Bifidobacterium adolescentis isolated from different hosts modifies the intestinal microbiota and displays differential metabolic and immunomodulatory properties in mice fed a high-fat diet. Nutrients 2021;13:1017.
93. Qian X, Si Q, Lin G, et al. Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity. Nutrients 2022;14:2479.
94. Botta C, Acquadro A, Greppi A, et al. Genomic assessment in Lactobacillus plantarum links the butyrogenic pathway with glutamine metabolism. Sci Rep 2017;7:15975.
95. Aiello A, Pizzolongo F, De Luca L, et al. Production of butyric acid by different strains of Lactobacillus plantarum
